Viking Therapeutics (VKTX) Earnings Date
The next earnings date for Viking Therapeutics (VKTX) is expected by Feb 16, 2027, per the data provider's calendar.
- Next earnings date
- Feb 16, 2027
- expected by · quarter ending Dec '26
- Consensus EPS
- $−1.38
- Dec '26 quarter · 13 analysts
- Consensus revenue
- $0.00
- Dec '26 quarter
- Latest stored quarter
- EPS −1.55
- revenue $0.00 · reported Oct 28, 2026
Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
1 of 1 scored quarter beat, yet the stock still fell after 1 of them (Jul 29, 2026). The market prices the whole print, not the headline beat. Chasing earnings pops is a coin flip.
| Report | Est EPS | Act EPS | Surprise | Est rev | Act rev | Reaction |
|---|---|---|---|---|---|---|
| Oct 28, 20268-K, after close · 4:05 pm ET | −1.06 | −1.55 | — | $0.00 | $0.00 | +5.9%next session |
| Jul 29, 20268-K, after close · 4:05 pm ET | −1.23 | −1.10 | +10.8% | $0.00 | $0.00 | −1.0%next session |
| Apr 29, 20268-K, after close · 4:05 pm ET | — | −1.37 | — | — | $0.00 | −0.5%next session |
| Feb 11, 20268-K, after close · 4:06 pm ET | — | −1.39 | — | — | — | +6.8%next session |
| Oct 22, 20258-K, after close · 4:10 pm ET | — | −0.81 | — | — | $0.00 | +8.0%next session |
| Jul 23, 20258-K, after close · 4:05 pm ET | — | −0.58 | — | — | $0.00 | +0.3%next session |
| Apr 23, 20258-K, after close · 4:05 pm ET | — | −0.41 | — | — | $0.00 | −0.5%next session |
| Feb 5, 20258-K, after close · 4:07 pm ET | — | −0.33 | — | — | — | −6.1%next session |
Estimate-vs-actual scoring began Jul 2026 and is still accruing: 1 of the 8 quarters above carries a scored estimate. We never backfill an estimate we didn't observe.
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 13 | 5 | 15 | 15 |
| Avg estimate | −1.38 | −1.35 | −5.37 | −5.28 |
| Low estimate | −1.72 | −1.58 | −5.77 | −6.32 |
| High estimate | −0.96 | −1.17 | −4.67 | −4.00 |
| Year-ago EPS | −1.39 | −1.37 | −3.19 | −5.37E |
| Implied growth | — | — | — | — |
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 0 | 0 | 9 | 10 |
| Avg estimate | $0.00 | $0.00 | $7.2M | $7.3M |
| Low estimate | $0.00 | $0.00 | $7.2M | $7.3M |
| High estimate | $0.00 | $0.00 | $7.2M | $7.3M |
| Year-ago revenue | — | $0.00 | $0.00 | $7.2ME |
| Implied growth | — | — | — | +2.5% |
| Snapshot age | Dec '26, period ending Dec 30, 2026 | Mar '27, period ending Mar 30, 2027 | FY26, period ending Dec 31, 2026 | FY27, period ending Dec 31, 2027 |
|---|---|---|---|---|
| Current estimate | −1.38 | −1.35 | −5.25 | −5.03 |
| 7 days ago | −1.38 | — | −5.25 | −5.03 |
| 30 days ago | −1.09 | — | −4.60 | −4.36 |
| 60 days ago | −1.10 | — | −4.61 | −4.39 |
| 90 days ago | −1.08 | — | −4.60 | −4.42 |
Estimate history accrues from our nightly snapshots. The 7/30/60/90-day rows fill in as tracking continues. Each column follows one fiscal period back through our snapshots; a dash means we had not recorded that period at that age. A rising bar makes a beat streak more meaningful; a falling one manufactures beats.
Dec '26 quarter consensus moved $−1.08 → $−1.38 over 90 tracked days, the same quarter at both ends. Per-analyst up/down revision counts aren't in our data feed. We show the bar's actual movement instead of guessing.
Common questions
When does Viking Therapeutics report earnings next?
Viking Therapeutics' next earnings date is expected by Feb 16, 2027, per the data provider's calendar.
What were Viking Therapeutics' latest quarterly earnings?
Viking Therapeutics reported diluted EPS of −1.55 and revenue of $0.00 on Oct 28, 2026.
How did Viking Therapeutics' stock move after its last earnings report?
Viking Therapeutics moved +5.9% in the session after its Oct 28, 2026 report.

